Greenwich LifeSciences, Inc.
NASDAQ:GLSIBiotechnology
-$0.74 today
- Market cap
- $302.08M
- Beta
- 1.38
- P/E (TTM)
- -15.6
- EPS (TTM)
- -$1.49
Volume 0.71M
Average 0.14M
GLSI Total Debt
Short-term and long-term borrowings combined.
Greenwich LifeSciences, Inc.NASDAQ: GLSI
Total Debt · Q1 FY2026 · quarter ended Mar 2026
Total debt remains negative
Q1 FY2026 total debt was $0, compared with $0 a year earlier.
Context
- Total debt amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Total debt increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Debt history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Total Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Total Debt vs competitors
How GLSI compares with its peers on the latest reported figures
- Peers report in different currencies, so total debt is compared through growth and share of total assets rather than absolute size.
- Total debt amounts to 0.0% of total assets for GLSI, versus a peer median of 5.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $304.46M USD | +230.8% | +62.2% | 163.3% | |
IRDOpus Genetics, Inc. | Mar 2026 | $25.93M USD | — | — | 38.8% |
| Mar 2026 | $23.03M USD | -9.4% | -7.5% | 8.5% | |
| Mar 2026 | $6.78M USD | -14.9% | +5.8% | 5.6% | |
| Mar 2026 | $1.04M USD | -2.0% | — | 1.1% | |
| Mar 2026 | CA$508K CAD | -49.2% | +27.5% | 6.2% | |
| Mar 2026 | $465K USD | -26.8% | -24.4% | 1.3% | |
| Mar 2026 | $456.93K USD | +177.6% | +71.7% | 1.5% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding GLSI) | — | -9.4% | +16.6% | 5.9% | |
Competitors are the stored peer set for GLSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Greenwich LifeSciences, Inc.
NASDAQ:GLSI
Intrinsic Alpha fair value
Locked
Current Price
$20.58
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.